Last checked at 26 Mar 2021 14:56
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 25 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,750,375 | 1.36% | 189,823 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,935 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,859,410 | 1.44% | 202,989 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 15 | 225.1700 USD |
Purchase | 31 | 222.6393 USD |
Purchase | 32 | 224.5050 USD |
Purchase | 46 | 224.3632 USD |
Purchase | 50 | 224.3900 USD |
Purchase | 69 | 223.8456 USD |
Purchase | 116 | 223.5129 USD |
Purchase | 120 | 224.1400 USD |
Purchase | 141 | 223.9708 USD |
Purchase | 224 | 223.2180 USD |
Purchase | 274 | 223.4471 USD |
Purchase | 354 | 224.2946 USD |
Purchase | 644 | 223.2246 USD |
Purchase | 666 | 223.9419 USD |
Purchase | 1,689 | 223.2568 USD |
Purchase | 1,994 | 223.4772 USD |
Purchase | 2,452 | 224.5000 USD |
Purchase | 2,941 | 224.4995 USD |
Purchase | 3,329 | 223.8667 USD |
Purchase | 4,893 | 224.2041 USD |
Purchase | 5,341 | 224.4856 USD |
Purchase | 5,831 | 223.5647 USD |
Purchase | 6,293 | 223.6108 USD |
Purchase | 16,629 | 223.5146 USD |
Purchase | 23,589 | 224.1750 USD |
Sale | 2 | 223.6950 USD |
Sale | 15 | 224.2400 USD |
Sale | 31 | 223.8800 USD |
Sale | 100 | 223.8400 USD |
Sale | 100 | 224.7100 USD |
Sale | 117 | 224.5858 USD |
Sale | 129 | 224.3317 USD |
Sale | 160 | 223.3871 USD |
Sale | 200 | 223.5800 USD |
Sale | 300 | 222.6866 USD |
Sale | 300 | 224.3200 USD |
Sale | 300 | 224.1600 USD |
Sale | 300 | 223.7100 USD |
Sale | 320 | 223.8190 USD |
Sale | 400 | 223.0775 USD |
Sale | 461 | 223.9125 USD |
Sale | 500 | 223.4590 USD |
Sale | 500 | 223.2180 USD |
Sale | 500 | 222.8310 USD |
Sale | 801 | 224.1668 USD |
Sale | 900 | 223.5116 USD |
Sale | 1,089 | 223.2889 USD |
Sale | 1,201 | 223.2566 USD |
Sale | 2,514 | 224.0712 USD |
Sale | 3,147 | 223.3418 USD |
Sale | 3,190 | 223.8723 USD |
Sale | 4,593 | 224.1966 USD |
Sale | 4,841 | 224.4978 USD |
Sale | 4,950 | 223.4838 USD |
Sale | 5,948 | 224.5000 USD |
Sale | 6,952 | 223.6220 USD |
Sale | 9,484 | 224.1224 USD |
Sale | 11,548 | 223.6114 USD |
Sale | 12,604 | 224.2232 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 26 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210326005328/en/
Copyright Business Wire 2021